Kliniske studier for HIV i Texas
23 studier for HIV søker deltakere på steder i Texas.
Byer i Texas
Offisiell studietekst (engelsk)
Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
- Abounding Prosperity Inc., Dallas
- Prism Health, Dallas
- UT Health, Houston
- og 1 flere
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07473778A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
- GSK Investigational Site, Austin
- GSK Investigational Site, Dallas
- GSK Investigational Site, Dallas
- og 2 flere
RekruttererFase 3
Alder 12 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07650916ADELANTE: A Randomized Controlled Trial to Improve Engagement in Care for Latinos With HIV
- Baylor College of Medicine, Houston
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06274632A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
- Saint Hope Foundation, Inc. ( Site 1504), Bellaire
- Prism Health North Texas, Oak Cliff Health Center ( Site 1514), Dallas
- Texas Center for Infectious Disease Associates ( Site 1502), Fort Worth
- og 1 flere
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 21. sep. 2026 · NCT07266831Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
- 5128, Baylor College of Medicine/Texas Children's Hospital Clinical Research Site, Houston
RekruttererFase 1/2
48 Hours · Alle kjønn · Oppdatert 9. sep. 2026 · NCT02140255Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
- M D Anderson Cancer Center, Houston
RekruttererFase 2
Alle aldre · Alle kjønn · Oppdatert 4. sep. 2026 · NCT02479698A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV
- The Crofoot Research Center, Houston
RekruttererFase 1Frivillige helsepersonell ønskes velkommen
Alder 18 til 50 · Alle kjønn · Oppdatert 21. aug. 2026 · NCT07698600Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
- University of Texas M.D. Anderson Cancer Center, Houston
Rekrutterer
Alder 45 til 80 · Alle kjønn · Oppdatert 19. aug. 2026 · NCT04949464Positive Peers Intervention Clinical Trial
- Thomas Street Clinic, Houston
Rekrutterer
Alder 13 til 34 · Alle kjønn · Oppdatert 18. aug. 2026 · NCT06388109Screen2Prevent (S2P)
- Baylor College of Medicine, Houston
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 14 til 24 · Alle kjønn · Oppdatert 17. aug. 2026 · NCT07728123Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
- North Texas Infectious Diseases Consultants, P.A., Dallas
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 14. aug. 2026 · NCT07682961First Time in Human Study of Long Acting VH4524184 Formulations
- GSK Investigational Site, San Antonio
RekruttererFase 1Frivillige helsepersonell ønskes velkommen
Alder 18 til 55 · Alle kjønn · Oppdatert 10. aug. 2026 · NCT06310551A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
- UT Health Houston, Houston
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. jul. 2026 · NCT07143968A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
- GSK Investigational Site, Bellaire
- GSK Investigational Site, Dallas
- GSK Investigational Site, Houston
- og 2 flere
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 23. jul. 2026 · NCT07202546Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)
- Houston Methodist Research Institute, Houston
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 22. jun. 2026 · NCT06263426Menopausal HT for Women Living With HIV (HoT)
- Houston AIDS Research Team CRS (31473), Houston
RekruttererFase 4
Alder 40 til 60 · Kvinner · Oppdatert 22. mai 2026 · NCT06856174Assessing the Use of MY-RIDE, a Just-in-time Adaptive Intervention, to Improve HIV Prevention and Substance Use in Youth Experiencing Homelessness
- The University of Texas Health Science Center at Houston, Houston
Rekrutterer
Alder 18 til 25 · Alle kjønn · Oppdatert 13. mai 2026 · NCT06074354HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients
- UT Southwestern Medical Center, Dallas
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 21. jan. 2026 · NCT06659952The Unlocking PrEP Study: Integration of Peer Health Navigation Into Comprehensive Re-entry Services
- UT Southwestern Medical Center, Dallas
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 18 til 99 · Alle kjønn · Oppdatert 15. jan. 2026 · NCT07292792A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
- GSK Investigational Site, Austin
RekruttererFase 1Frivillige helsepersonell ønskes velkommen
Alder 18 til 55 · Alle kjønn · Oppdatert 18. des. 2025 · NCT05418868Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
- UT Health Houston, Houston
RekruttererFase 2
Alder 40 og eldre · Alle kjønn · Oppdatert 17. des. 2025 · NCT05488431A Study to Assess the Safety, Tolerability, and Pharmacokinetics of VH4011499 Compared to Placebo in Adults Without HIV
- GSK Investigational Site, Austin
RekruttererFase 1Frivillige helsepersonell ønskes velkommen
Alder 18 til 55 · Alle kjønn · Oppdatert 29. okt. 2025 · NCT06724640Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
- GSK Investigational Site, Houston
- GSK Investigational Site, Houston
RekruttererFase 1/2
Alder 6 til 12 · Alle kjønn · Oppdatert 19. sep. 2024 · NCT05674656Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.